Related Experiment Videos
Revisiting the need for bone marrow examination in chronic myeloid leukemia
Ayalew Tefferi1, Curtis A Hanson2, Rhett P Ketterling3
1Divisions of Hematology, Mayo Clinic, Rochester, Minnesota.
American Journal of Hematology
|October 14, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Selinexor for myelofibrosis or a drug in search of a disease?
Blood cancer journal·2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.
American journal of hematology·2026
Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.
Blood cancer journal·2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
American journal of hematology·2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.
American journal of hematology·2026